Publications View
Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins.
Authors: Authors: Petasis NA, Akritopoulou-Zanze I, Fokin VV, Bernasconi G, Keledjian R, Yang R, Uddin J, Nagulapalli KC, Serhan CN.
Prostaglandins Leukot Essent Fatty Acids
View full abstract on Pubmed
Prostaglandins Leukot Essent Fatty Acids
View full abstract on Pubmed
Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins.
Authors: Authors: Petasis NA, Akritopoulou-Zanze I, Fokin VV, Bernasconi G, Keledjian R, Yang R, Uddin J, Nagulapalli KC, Serhan CN.
Prostaglandins Leukot Essent Fatty Acids
View full abstract on Pubmed
Prostaglandins Leukot Essent Fatty Acids
View full abstract on Pubmed
Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX.
Authors: Authors: Chiang N, Arita M, Serhan CN.
Prostaglandins Leukot Essent Fatty Acids
View full abstract on Pubmed
Prostaglandins Leukot Essent Fatty Acids
View full abstract on Pubmed
Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX.
Authors: Authors: Chiang N, Arita M, Serhan CN.
Prostaglandins Leukot Essent Fatty Acids
View full abstract on Pubmed
Prostaglandins Leukot Essent Fatty Acids
View full abstract on Pubmed
Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
Clues for new therapeutics in osteoporosis and periodontal disease: new roles for lipoxygenases?
Clues for new therapeutics in osteoporosis and periodontal disease: new roles for lipoxygenases?
Aspirin triggers formation of anti-inflammatory mediators: New mechanism for an old drug.
Aspirin triggers formation of anti-inflammatory mediators: New mechanism for an old drug.
Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers.